EyeGate Pharma Enrolls First Patient in Follow-on PE Pilot Study
Go back to EyeGate Pharma Enrolls First Patient in Follow-on PE Pilot Study| (NASDAQ: EYEG) | Delayed: 33.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.99 | 52 Week High | $5.09 | |||
| Open | $33.99 | 52 Week Low | $1.11 | |||
| Day High | $33.99 | P/E | N/A | |||
| Day Low | $33.99 | EPS | $0.00 | |||
| Volume | 250 | |||||
